KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Exchange Rate Effect (2016 - 2025)

NovoCure's Exchange Rate Effect history spans 10 years, with the latest figure at -$76000.0 for Q4 2025.

  • For Q4 2025, Exchange Rate Effect rose 40.62% year-over-year to -$76000.0; the TTM value through Dec 2025 reached $394000.0, up 326.44%, while the annual FY2025 figure was $394000.0, 326.44% up from the prior year.
  • Exchange Rate Effect for Q4 2025 was -$76000.0 at NovoCure, down from -$22000.0 in the prior quarter.
  • Across five years, Exchange Rate Effect topped out at $265000.0 in Q2 2025 and bottomed at -$128000.0 in Q4 2024.
  • The 5-year median for Exchange Rate Effect is -$29500.0 (2021), against an average of $3300.0.
  • The largest annual shift saw Exchange Rate Effect tumbled 3900.0% in 2022 before it surged 505.36% in 2025.
  • A 5-year view of Exchange Rate Effect shows it stood at -$49000.0 in 2021, then skyrocketed by 416.33% to $155000.0 in 2022, then increased by 29.03% to $200000.0 in 2023, then tumbled by 164.0% to -$128000.0 in 2024, then surged by 40.62% to -$76000.0 in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Exchange Rate Effect are -$76000.0 (Q4 2025), -$22000.0 (Q3 2025), and $265000.0 (Q2 2025).